Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A 20-year-old girl with an unusual febrile illness.
Castoldi R, Bai F, Caberlon S, Ferrari D, Moro A, Podda GM, d'Arminio Monforte A, Marchetti GC. Castoldi R, et al. Among authors: caberlon s. Intern Emerg Med. 2022 Jan;17(1):181-186. doi: 10.1007/s11739-020-02605-8. Epub 2021 Jan 5. Intern Emerg Med. 2022. PMID: 33400162 Free PMC article. No abstract available.
A case of newly diagnosed immune thrombocytopenia in the COVID-19 era.
Clerici B, Birocchi S, Bertinato E, Di Benedetto C, Caberlon S, Cattaneo M, Podda GM. Clerici B, et al. Among authors: caberlon s. Intern Emerg Med. 2021 Nov;16(8):2221-2225. doi: 10.1007/s11739-020-02553-3. Epub 2020 Nov 12. Intern Emerg Med. 2021. PMID: 33180223 Free PMC article. No abstract available.
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.
Vannucchi AM, Antonioli E, Guglielmelli P, Rambaldi A, Barosi G, Marchioli R, Marfisi RM, Finazzi G, Guerini V, Fabris F, Randi ML, De Stefano V, Caberlon S, Tafuri A, Ruggeri M, Specchia G, Liso V, Rossi E, Pogliani E, Gugliotta L, Bosi A, Barbui T. Vannucchi AM, et al. Among authors: caberlon s. Blood. 2007 Aug 1;110(3):840-6. doi: 10.1182/blood-2006-12-064287. Epub 2007 Mar 22. Blood. 2007. PMID: 17379742 Free article.
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis.
Maffioli M, Mora B, Ball S, Iurlo A, Elli EM, Finazzi MC, Polverelli N, Rumi E, Caramella M, Carraro MC, D'Adda M, Molteni A, Sissa C, Lunghi F, Vismara A, Ubezio M, Guidetti A, Caberlon S, Anghilieri M, Komrokji R, Cattaneo D, Della Porta MG, Giorgino T, Bertù L, Brociner M, Kuykendall A, Passamonti F. Maffioli M, et al. Among authors: caberlon s. Blood Adv. 2022 Mar 22;6(6):1855-1864. doi: 10.1182/bloodadvances.2021006889. Blood Adv. 2022. PMID: 35130339 Free PMC article.
16 results